, ME, PF, BL
Statistical analysis: JR, AA, EA, ME, PF, BL
Obtained funding: Not applicable.
Overall responsibility: JR
REFERENCES
1. Fields WS, North RR, Hass WK, Kircheff II, Chase NE, Bauer RB, et
al. Joint study of extracranial arterial occlusion as a cause of Stroke. I.
Organization of study and survey of patient population. JAMA 1968;
203:955-60.
2. North American Symptomatic Carotid Endarterectomy Trial Collaborators (NASCET). Beneficial effect of carotid endarterectomy in
symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators N Engl
J Med 1991;325:445.
3. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes
RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:
1415-25.
4. Randomised trial of endarterectomy for recently symptomatic carotid
stenosis: final results of the MRC European Carotid Surgery Trial
(ECST). Lancet 1998;351:1379-87.
5. Endarterectomy for asymptomatic carotid artery stenosis. Executive
Committee for the Asymptomatic Carotid Atherosclerosis Study.
JAMA 1995;273:1421-8.
6. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al.
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004;363:1491-502.
7. Eslami MH, McPhee JT, Simons JP, Schanzer A, Messina LM. National trends in utilization and postprocedure outcomes for carotid
revascular